Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Debiopharm Group™ Presents The ‘JCA Mauvernay Award 2013’

Published: Tuesday, October 08, 2013
Last Updated: Monday, October 07, 2013
Bookmark and Share
Doctors Kitabayashi and Yano will receive awards during the General Assembly of the 72nd Annual Conference of the JCA in Yokohama.

Debiopharm Group™ (Debiopharm) will be presenting the ‘JCA-Mauvernay Award’ on October 5, to Doctors Issay Kitabayashi from Tokyo National Cancer Center Research Institute for his basic research on ‘Molecular study of acute myeloid leukemia and its application for therapy’ and Seiji Yano from Kanazawa University for his applied research on ‘Circumvention of molecular targeted drug resistance in lung cancer’.

Doctors Kitabayashi and Yano will receive their Awards during the General Assembly of the 72nd Annual Conference of the Japanese Cancer Association (JCA) in Yokohama on the following theme: ‘Cancer research providing hope to fight against cancer’.

Dr. Tetsuo Noda, President of the JCA and a Debiopharm Group representative will present the trophies to both scientists.

“The selecting committee members chose the nominees for the high standard and application possibilities of their research. Debiopharm is honored to be part of this Award with the JCA and wishes both scientists success with their work,” said Rolland-Yves Mauvernay, President and founder of Debiopharm Group™.

Dr Kitabayashi focuses on the molecular study of the basis of the development of acute myeloid leukemia (AML). He shows that it is related to chromosomal rearrangements modifying the function of genes involved in transcription and hematopoiesis (AML1, PML, MOZ).

Molecular drugs like EGFR (epidermal growth factor receptor) tyrosine kinase inhibitors (TKIs) show dramatic effects in lung cancer patients. However resistance to EGFR-TKIs is a major problem in current clinical practice.

Dr Yano aims to conduct clinical trials to elucidate and overcome the molecular mechanisms involved in the resistance to lung cancer drugs and to establish treatments to overcome it.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Oncotest and Debiopharm Announce a Successful Partnership
Successful completion of first biomarker projects at Oncotest.
Wednesday, April 24, 2013
Curis and Debiopharm Announce Initiation of Phase I-II Clinical Study of HSP90 Inhibitor
Study to test Debio 0932 in patients with advanced non-small cell lung cancer.
Friday, August 17, 2012
Debiopharm and Vifor Pharma Sign an Exclusive Agreement
Distribution and commercialization of Pamorelin® LA in Switzerland.
Monday, May 21, 2012
Scientific News
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Editing Gene Mutations in Anemia
Researchers successfully use a new gene editing strategy to correct mutations that cause a form of anemia.
Genes Help Track Odd Migrations of Zika Mosquitoes
Study shows that mosquitoes carrying Zika virus or Dengue fever a genetically distinct around the world.
Nanomedicine Aims to Improve HIV Drug Therapies
New research aims to improve the administration and availability of drug therapies to HIV patients using nanotechnology.
Tumor Markers Reveal Lethality Of Bladder Cancers
Researchers found that detection of certain tumor cells in early stage cancers helps identify high-risk cancers.
Gene Editing Corrects Sickle Cell Mutation
Researchers demonstrate a potential pathway to developing gene-editing treatments for sickle cell disease.
Driving Mosquito Evolution to Fight Malaria
Researchers propose insect repellent in conjunction with insecticides to extend current insecticide lifetime.
Lab-on-a-Chip to Help Detect Cancer
In this podcast, we speak to Gustavo Stolovitsky to learn about his career and the work he is doing at IBM Research.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos